Company news
Imunon, Inc. news in 2022
Imunon, Inc.'s news releases, calls and decks from 2022, newest first.
IMUNON Reports Inducement Grants under NASDQ Listing Rule 5646(c)(4)
December 13, 2022
IMUNON Announces Strategic Investment in Transomic Technologies
November 16, 2022
IMUNON Reports Third Quarter 2022 Financial Results and Provides Business Update
November 13, 2022
IMUNON Enters into Technology Evaluation Agreement with Acuitas Therapeutics to Evaluate IMUNON’s PLACCINE Plasmid DNA with Acuitas’ Lipid Nanoparticle Delivery System
November 9, 2022
Imunon Appoints James E. Dentzer to its Board of Directors
October 2, 2022
Calls in 2022
Decks in 2022
- World Vaccine & Immunotherapy Congress 2022
Conference · 27 slides · Dec 1, 2022
- Investor Presentation (November 2022)
Investor deck · 32 slides · Nov 15, 2022
- Chardan's 6th Annual Genetic Medicines Conference 2022
Conference · 30 slides · Oct 3, 2022
- Celsion — Investor Presentation (June 2022)
Investor deck · 39 slides · June 2022
- Celsion — Technical Presentation (February 2022)
Technical · 27 slides · February 2022